***This website will be offline for scheduled maintenance from Friday, December 2, 2022, at 9:00 PM ET until 2:00 PM ET on Saturday, December 3, 2022.***
Welcome to the Fact Sheet Exchange Portal for MDL 2592 In Re Xarelto (Rivaroxaban) Products Liability Litigation
Welcome to MDL Centrality. In its Pre-Trial Order regarding Plaintiff and Defendant Fact Sheets, the United States District Court for the Eastern District of Louisiana ordered all parties to use MDL Centrality to exchange Plaintiff and Defendant Fact Sheets electronically.

If you already have access to MDL Centrality for another case, you may use the same login ID and password to log in below. If you need access to MDL Centrality, click here to register on the main website. If you need assistance, please contact us at MDLCentrality@browngreer.com.
Unauthorized use of this system is prohibited. Use is restricted to authorized users. Violators may be subject to disciplinary actions including civil and criminal prosecution and loss of employment. All transactions are monitored.